Hypocholesterolemia in hairy cell leukemia: A marker for proliferative activity

American Journal of Hematology

Volumn 55, Issue 3, 1997, Pages 129-133

  Pandolfino, John ^a   Hakimian, David ^a   Rademaker, Alfred W ^a   Tallman, Martin S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hairy cell leukemia; Hypocholesterolemia; Proliferative activity

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; CLADRIBINE;

ADULT; ARTICLE; BODY BURDEN; CANCER CHEMOTHERAPY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HYPOCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CELL DIVISION; CHOLESTEROL; CLADRIBINE; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SPLENOMEGALY;

EID: 0030844762     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199707)55:3<129::AID-AJH2>3.0.CO;2-U     Document Type: Article

References (32)

1. Gilbert HS, Ginsberg H, Faegerstrom R, Brown WV: Characterization of the hypocholesterolemia in myeloproliterative disease: Relation to disease manifestation and activity. Am J Med 71:595-602, 1981.
2. Ginsberg H, Gilbert HS, Gibson JC, Le NA, Brown WV: Increased low-density lipoprotein catabolism in myeloproliferative disorders. Ann Intern Med 96:311-316, 1982.
3. Aviram M, Brook JG, Tatarsky I, Levy Y, Carter A: Increased low-density lipoprotein levels after splenectomy: A role for the spleen in cholesterol metabolism in myeloproliferative disorders. Am J Med Sci 29:25-28, 1986.
4. Gilbert HS, Ginsberg H: Hypocholesterolemia as a manifestation of disease activity in chronic myelocytic leukemia. Cancer 51:1428-1433, 1983.
5. Budd D, Ginsberg H: Hypocholesterolemia and acute myelogenous leukemia. Cancer 58:1361-1365, 1986.
6. Reverter CJ, Sierra J, Msrti-Tutudsaus JM: Hypocholesterolemia in acute myelogenous leukemia. Eur J Haematol 41:317-320, 1988.
7. Porta C, Moroni M, Nastasi G: Hypocholesterolemia and acute myeloid leukemia (AML). Haematologica 76:348, 1991.
8. Shokunni WA, Ahaneku JE, Okpala IE: Cholesterol, lipoprotein and phospholipid levels in acute lymphoblastic leukemia. Eur J Haematol 46:59-61, 1991.
9. Baroni S, Scriban D, Paguno L, Zuppi C, Leone G, Gurdina B: Lipids and lipoproteins in acute lymphoblastic leukemia (ALL). Leukemia Res 18:643-644, 1994.
10. Marini A, Carulli G, Azzara A, Grassi B, Ambrogi F: Serum cholesterol and triglycerides in hematologic malignancies. Acta Haematol 81:75-79, 1989.
11. Rifkind BM, Gale M: Hypolipidemia in anemia. Cancer 2:640-644, 1967.
12. Traber MG, Kayden HS: Low-density lipoprotein-receptor activity in human monocyte-derived macrophages and its relation to atheromatous lesions. Proc Natl Acad Sci 77:5466-5470, 1980.
13. Golomb HM, Catovsky D, Golde DW: Hairy cell leukemia: A clinical review based on 71 cases. Ann Intern Med 89:677-683, 1978.
14. Tallman MS, Hakimian D, Vanakojis D, Koslow D, Sisney GA, Rademaker AW, Rose E, Kaul K: A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80:2203-2209, 1992.
15. Cools L, Osteaux M, Divano L, Jeanmart L: Prediction of splenic volume by simple CT measurement: A statistical study. J Comput Assist Tomogr 7:426-430, 1983.
16. Golomb HM, Vardiman J: Response to splenectomy in 65 patients with HCL: Evaluation of spleen weight and bone marrow involvement. Blood 61:349-352, 1983.
17. Rosner B: "Fundamentals of Biostatistics." Ed. 4. Belmont, CA: Duxbury Press, 1994.
18. Anonymous: Trends in serum cholesterol levels among US adults aged 20 to 74 years. Data from the National Health and Nutrition Examination Surveys, 1960-1980. National Center for Health Statistics-National Heart, Lung and Blood Institute Collaborative Lipid Group. JAMA 257:937-942, 1987.
19. Cooper GR, Meyer GL, Smith SJ, Schlant RC: Blood lipid measurements: Variations and practical utility. JAMA 267:1652-1660, 1992.
20. Chen HW, Kandutsch AA, Heiniger HJ: The role of cholesterol in malignancy. Prog Exp Tumor Res 22:275-316, 1978.
21. Ho YK, Smith G, Brown MS, Goldstein JL: Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099-1114, 1978.
22. Liebes LF, Pelle E, Zucker-Franklin D, Silber R: Comparison of lipid composition and 1,6-diphenyl-1,3,5,hexatriene fluorescence polarization measurements of hairy cell with monocytes and lymphocytes from normal subjects and patients with chronic lymphocytic leukemia. Cancer Res 41:4050-4056, 1981.
23. Golomb HM, Safford CW, Nathans AH, Dawson G: Phospholipid and cholesterol differences amongst leukemic cell types with special reference to hairy cell leukemia: A preliminary report. Clin Chem Acta 116:311-318, 1981.
24. Yachnin S, Larson RA, West JE: Rates of cholesterol biosynthesis are related to early differentiation in acute nonlymphocytic leukemia cells. Br J Haematol 54:459-466, 1983.
25. Juliusson G, Vitols S, Liliemark J: Mechanisms behind hypocholesterol in hairy cell leukemia. BMJ 311:27, 1995.
26. Kawasaki H, Carrera CJ, Piro LD, Saven A, Kipps TJ, Carson DA: Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood 81:597-601, 1993.
27. Lechleitner M, Auer B, Zilian U, Hoppicher F, Schirmer M, Foger B, Geisen F, Patsson JR, Konwalinka G: The immunosuppressive substance 2-chlor-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (p388 cells). Lipids 29:627-633, 1994.
28. Mohandas T, Heinzman C, Sparkes RS, Wasmuth J, Edwards P, Lusis AJ: Assignment of human 3-hydroxy-3-methylglutaryl coenzyme A reduetase gene to q13-q23 region of chromosome 5. Somatic Cell Mol Genet 12:89-94, 1986.
29. Haglund U, Julivsson G, Birgitta S, Gosta G: Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 83:2637-2645, 1994.
30. Vitols S, Angelin B, Ericsson S, Garhton G, Juliusson G, Masquelier M, Paul C, Peterson C, Rudling M, Soderberg-Reid K, Tidefelt V: Uptake of low-density lipoprotein by human leukemic cells in vivo: Relation to plasma lipoprotein levels and possible relevance for selective chemotherapy. Proc Natl Acad Sci USA 87:2598-2602, 1990.
31. Bansal N, Houle AG, Melnykovych G: Comparison of dexamethasone and lovastatin (Mevinolin) as growth inhibitors in cultures of T-cell derived human acute leukemic cell lines (CEM). Leukemia Res 13: 875-882, 1989.
32. Seymour JF, Kurzrock R, Freireich EJ, Estey EH: 2-chlorodeoxyadenosine induces durable and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906-2911, 1994.